Rivaroxaban: Expanded Role in Cardiovascular Disease Management—A Literature Review
Direct oral anticoagulants (DOACs) are widely used for the prevention of stroke in nonvalvular atrial fibrillation, treatment of deep venous thrombosis and pulmonary embolism, and as prophylaxis after hip and knee surgery after approval by the Food and Drug Administration. In the last decade, DOACs...
Saved in:
Main Authors: | Muhammad Ajmal, Jacob Friedman, Qurat Ul Ain Riaz Sipra, Tom Lassar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2021/8886210 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rivaroxaban and Hemostasis in Emergency Care
by: Jürgen Koscielny, et al.
Published: (2014-01-01) -
Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization
by: Min Lu, et al.
Published: (2025-01-01) -
A Case of Granulomatosis with Polyangiitis in Pregnancy
by: Rashid Naseem Khan, et al.
Published: (2025-01-01) -
Life-Threatening Hemopericardium Associated with Rivaroxaban
by: Sijan Basnet, et al.
Published: (2017-01-01) -
Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy
by: Jonathan M. Yaghoubian, et al.
Published: (2017-01-01)